2014
Esc
Meier P, Lansky AJ, Baumbach A. Esc. Acta Cardiologica 2014, 69: 100-108. PMID: 24640527, DOI: 10.1080/ac.69.1.3011351.Peer-Reviewed Original ResearchMeSH KeywordsAcute Coronary SyndromeDeath, Sudden, CardiacElectrocardiographyHumansMonitoring, PhysiologicMyocardial InfarctionOutcome Assessment, Health CarePercutaneous Coronary InterventionPlatelet Aggregation InhibitorsTime-to-TreatmentTomography, Optical CoherenceUltrasonography, InterventionalConceptsST-elevation myocardial infarctionAcute coronary syndromeCardiac arrestUnstable coronary artery plaqueRecent therapeutic progressElevation myocardial infarctionNovel antiplatelet agentsCoronary artery plaquesSudden cardiac arrestCommon underlying causeACS mortalityElevation infarctionCoronary syndromeUnstable anginaAntiplatelet agentsArtery plaquesMyocardial infarctionTherapeutic progressUnderlying causeInfarctionArrestAnginaCangrelorPrasugrelTicagrelor
2004
High-dose 7-hexanoyltaxol-eluting stent with polymer sleeves for coronary revascularizationOne-year results from the SCORE randomized trial
GRUBE E, LANSKY A, HAUPTMANN K, DIMARIO C, DISCIASCIO G, COLOMBO A, SILBER S, STUMPF J, REIFART N, FAJADET J. High-dose 7-hexanoyltaxol-eluting stent with polymer sleeves for coronary revascularizationOne-year results from the SCORE randomized trial. Journal Of The American College Of Cardiology 2004, 44: 1368-1372. DOI: 10.1016/s0735-1097(04)01351-8.Peer-Reviewed Original ResearchConceptsRestenosis rateStent thrombosisMajor adverse cardiac event ratesAdverse cardiac event ratesDe novo coronary lesionsTarget vessel revascularization rateEnd pointNon-Q-wave MIAngiographic restenosis rateCardiac event rateNovo coronary lesionsPrimary end pointUnacceptable safety profileVessel revascularization rateMyocardial infarction rateOpen-label trialStent thrombosis ratesClinical end pointsOne-year resultsQuantitative coronary angiographyCoronary revascularizationRevascularization ratesInfarction rateCardiac deathCoronary angiographyHigh-dose 7-hexanoyltaxol-eluting stent with polymer sleeves for coronary revascularization One-year results from the SCORE randomized trial
Grube E, Lansky A, Hauptmann K, Di Mario C, Di Sciascio G, Colombo A, Silber S, Stumpf J, Reifart N, Fajadet J, Marzocchi A, Schofer J, Dumas P, Hoffmann R, Guagliumi G, Pitney M, Russell M. High-dose 7-hexanoyltaxol-eluting stent with polymer sleeves for coronary revascularization One-year results from the SCORE randomized trial. Journal Of The American College Of Cardiology 2004, 44: 1368-1372. PMID: 15464315, DOI: 10.1016/j.jacc.2004.06.054.Peer-Reviewed Original ResearchConceptsRestenosis rateStent thrombosisMajor adverse cardiac event ratesAdverse cardiac event ratesDe novo coronary lesionsTarget vessel revascularization rateEnd pointNon-Q-wave MIAngiographic restenosis rateCardiac event rateNovo coronary lesionsPrimary end pointUnacceptable safety profileVessel revascularization rateMyocardial infarction rateOpen-label trialStent thrombosis ratesClinical end pointsOne-year resultsQuantitative coronary angiographyCoronary revascularizationRevascularization ratesInfarction rateCardiac deathCoronary angiography
2003
Comparison of in-hospital and one-year outcomes after multiple coronary arterial stenting in patients ≥80 years old versus those <80 years old
Kobayashi Y, Mehran R, Mintz GS, Dangas G, Moussa I, Lansky AJ, Stone GW, Moses JW, Leon MB. Comparison of in-hospital and one-year outcomes after multiple coronary arterial stenting in patients ≥80 years old versus those <80 years old. The American Journal Of Cardiology 2003, 92: 443-446. PMID: 12914876, DOI: 10.1016/s0002-9149(03)00663-5.Peer-Reviewed Original ResearchConceptsHigh technical success rateCoronary arterial stentingOne-year outcomesTechnical success rateHigh mortality rateComplication rateMultivessel stentingArterial stentingHospital cardiacMortality rateYounger counterpartsSuccess rateStentingPatientsHospitalPresent studyOutcomesYearsMultivesselOctogenariansCardiac